Dr. Szewczuk is Full Professor of Immunology and Medicine over 38 years at Queenâ€™s University, Kingston, Ontario Canada. Dr. Szewczukâ€™s research has focused on the role of glycosylation in receptor activation with a particular focus of Toll-like, neurotrophin Trk, EGFR and insulin receptors. A novel receptor-signalling platform was discovered, and its targeted translation in multistage tumorigenesis. He is now in the development of engineered drug delivery systems.
Copyright © Madridge 2019. All rights reserved.